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A substantial number of human tumors (~10%) are telomerase 
negative, and cells in such tumors have been proposed to main-
tain telomere length by the alternative lengthening of telomeres 
(ALT) pathway. Although details of the molecular mechanism 
of ALT are largely unknown, previous studies have shown that 
telomere homologous recombination (HR) is implicated in the 
ALT pathway. MUS81 is a DNA structure-specific recombina-
tion endonuclease and functions on aberrant DNA replication 
and recombination. Recently, we demonstrate that MUS81 plays 
a key role in the maintenance of telomeres in ALT cells (Zeng, 
et al. Nature Cell Biology, 2009). The MUS81 endonuclease 
specifically localizes to ALT-associated promyelocytic leukemia 
nuclear bodies (APBs) and interacts with telomeres in ALT cells. 
Depletion of MUS81 leads to reduced telomere recombination 
resulting in the growth arrest of ALT cells. The endonuclease 
activity of MUS81, regulated by its binding partner TRF2, is 
found to be essential for telomere post-replicative recombina-
tion. This study provides the first direct evidence that MUS81 
specifically functions on ALT recombination-based cell survival. 
The specific function of MUS81 on the ALT pathway provides 
a potential powerful diagnostic marker and a therapeutic target 
for ALT tumors.
Telomere Maintenance and Telomere Recombination
Telomeres are specialized structures at chromosome ends 
consisting of tandem repetitive DNA sequences [(TTAGGG)n in 
humans] and associated proteins, which are necessary for telomere 
function. The structure and function of telomeres are regulated by 
a multiprotein complex termed “shelterin,”2,3 which allows cells to 
distinguish natural chromosome ends from DNA double-strand 
breaks and maintains telomere length and stability. Progressive 
telomere shortening in normal cells during DNA replication leads 
eventually to a permanent halt of cell division referred to as replica-
tive senescence. This end replication problem of human telomeres 
has received particular attention due to its implications in ageing 
and cancer. Most human tumor cells acquire indefinite replica-
tive capacity to escape from the normal proliferative limitations 
through maintaining their telomeres, either by telomerase4 or by 
an alternative lengthening of telomeres (ALT) mechanism.5,6
Telomerase-negative cancer cells maintain their telomeres 
via the alternative lengthening of telomeres (ALT) pathway. 
Although a growing body of evidence demonstrates that the ALT 
mechanism is a post-replicative telomere recombination process, 
molecular details of this pathway are largely unknown.7-10 In 
particular, the highly significant increase in the number of post-
replicative telomere exchanges demonstrates that the ALT pathway 
is HR-dependent.9,11 The increased telomere recombination is 
ALT-specific and extends the proliferative life of ALT cells.12 A 
growing body of evidence hints that HR proteins and telomere 
associated proteins play a primary role in the ALT pathway. 
These proteins co-localize with telomeric (TTAGGG)n repeats 
at nuclear substructures known as ALT-associated promyelocytic 
leukemia (PML) nuclear bodies (APBs), which are present only 
in ALT cells.6,13-15 Imaging of live cells has revealed that an indi-
vidual telomere may move in and out of contact with an APB,16 
suggesting possible on-going telomere extension in ALT cells. 
Additionally, APBs are enriched during the G2 phase of the cell 
cycle when HR is most active and ALT activity is likely occur-
ring.17-19 APBs preferentially accumulate linear extrachromosomal 
telomeric DNA, which may provide DNA substrates for telomere 
recombination.20 ALT has only been detected in abnormal situa-
tions, such as tumor-derived cell lines or cell lines immortalized in 
vitro. It seems likely that ALT occurs due to a dysfunction in the 
highly regulated mechanisms controlling telomere recombination.
Activities of MUS81 in ALT Cells
MUS81, a highly conserved DNA structure-specific endonu-
clease, is required for the survival of cells undergoing aberrant 
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replication and recombination.21-24 
MUS81 functions as an endonu-
clease by cleaving intact and nicked 
Holliday junctions, replication 
forks, 3' flap and D-loop substrates 
which are preferred for DNA repli-
cation and recombination.21,22,24-27 
RNA interference experiments 
show that MUS81 is required for 
mitotic recombination in somatic 
human cells.21 MUS81 homozy-
gote and heterozygote knockout 
mice have a predisposition to 
develop cancer28 and show sensi-
tivity to agents that stall replication 
forks, such as hydroxyurea, methyl 
methane sulfonate and mitomycin 
C.28,29 Because MUS81 func-
tions on aberrant DNA replication 
and recombination, it is a candi-
date “ALT protein”, which might 
be required for abnormal telomere 
recombination in ALT cells.
In our recent study,1 we have 
demonstrated that the MUS81 
endonuclease specifically localizes to 
APBs and associates with telomeric 
DNA in ALT cells, which is enriched 
during G2 phase of the cell cycle 
(Fig. 1). Knockdown of MUS81 
results in reduction of ALT specific-
telomere recombination leading to 
proliferation arrest of ALT cells. 
Furthermore,  proliferation of ALT cell requires the endonuclease 
activity of MUS81, and the interaction of MUS81 with TRF2 
regulates this enzymatic activity to maintain telomere recombina-
tion. Thus, our results indicate that MUS81 is essential for ALT 
cell viability by ensuring efficient telomere recombination.
Role of MUS81 in Telomere Recombination
We find that MUS81 contributes to ALT cell survival 
by promoting telomere recombination.1 In yeast, MUS81 is 
required for the survival of cells undergoing aberrant replica-
tion and recombination.22,24 However, the biological functions 
of MUS81 in human cells are largely unknown. A variety of 
models predict the formation and resolution of different DNA 
structures during homologous recombination.21-24 These struc-
tures include 3' flaps, forks, D-loops, nicked, gapped and intact 
Holliday junctions. Recent studies have indicated that these 
structures are possible in vivo substrates of MUS81.30-32 Our 
results show that cleavage of telomere recombination substrates 
by MUS81 may be necessary for ALT cells survival, directly 
linking MUS81 endonuclease activity with abnormal telomere 
recombination in ALT cells. In addition, we present evidence 
indicating that telomere maintenance in the ALT pathway is 
a post-replicative recombination process, which is essential for 
ALT cell survival. MUS81 does not regulate telomere mainte-
nance in non-ALT cells, in agreement with the hypothesis that 
MUS81 only functions on abnormal DNA recombination, such 
as in ALT cells with a high frequency of telomere recombination. 
Our studies also provide clues for studying functions of MUS81 
in other biological processes, for example, in DNA damage and 
repair pathways.
We carefully examine telomere length after depletion of MUS81 
by using Q-FISH and TRF assays and do not observe significant 
telomere length changes. One possibility is that telomere recom-
bination leads to unequal sister chromatid exchange (SCE) at 
telomeres, which is responsible for rapid telomere elongation and 
shortening events. Before mitosis, telomere recombination leads 
to exchanges of equal amounts of telomeric DNA or results in a 
net gain of telomere sequences in one chromatid and a net loss in 
the other. Thus, the average changes of telomere length are not 
significantly altered. The Q-FISH and TRF assays could only 
detect the overall changes of telomere length and could not address 
on the specific chromosomes. This interpretation is consistent 
with a current model, which indicates maintenance of telomeres 
by unequal telomere SCE.12 Because telomeres are repetitive 
MUS81 in telomerase negative cells
Figure 1. Cell cycle-dependent MUS81 foci formation in ALT cells. U2OS cells (ALT cells) were blocked by 
double thymidine treatment and released from 5 hours (S phase) or 13 hours with an additional block by 
Hoechst 33342 (G2 phase). G0/G1 cells were obtained by methionine restriction treatment for 4 days. 
FACS analysis was conducted to confirm cell cycle phases (data not shown). Cells were stained with immu-
nofluoresence combined with telomeric DNA-FISH. Bright foci staining of FITC-labeled PNA probe (telomeric 
C-strand oligo) indicated APBs MUS81 proteins were stained by MUS81 antibody and an Alexa Fluor 
568-conjugated anti-mouse IgG (Molecular Probes). The merged images showed that MUS81 co-localized 
with telomeric DNA in APBs. The percentage of cells with co-localization of MUS81 foci with telomeric DNA 
(PNA probe) is shown. At least 200 cells were scored, and results were summarized from three independent 
experiments.
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telomerase-positive cells,34 suggesting that MUS81 is 
recruited into APBs in ALT cells. These results support 
a model that activation of the ALT pathway is through 
recruiting “ALT proteins” to telomeres.14
A recent study reports that the proportion of ALT cells 
with APBs is increased following methionine starvation.15 
These induced APBs contain TRF1, TRF2, TIN2, RAP1, 
the PML protein, the MRN complex, 53BP1, SP100 and 
telomeric DNA. We have also observed induction of APBs 
containing telomeric DNA upon methionine restriction. 
However, MUS81 is not present in these induced APBs 
in G0/G1 phase cells (data no shown), indicating that it 
might be a specific effect of the methionine starvation on 
MUS81 cellular metabolism/localization. These results 
also suggest that APBs may have different functions in 
different phases of the cell cycle. APBs in G2 phase cells 
may help to conduct telomere recombination. Unlike 
other recombination and telomere associated proteins 
present in APBs, MUS81 to APBs is only enriched in G2 
phase cells. This implies that MUS81 specifically func-
tions on the ALT pathway, and not on global telomere 
maintenance. These results also implicate that the localization of 
MUS81 in ALT might be a unique marker for ALT tumors.
Interaction of TRF2 and MUS81 in the ALT Pathway
TRF2 is thought to be a suppressor for telomere recombi-
nation,3,10 although the mechanism by which TRF2 governs 
telomere recombination is unclear. We find that TRF2 forms 
a complex with MUS81, inhibits the endonuclease activity of 
MUS81 by suppressing MUS81 binding to the DNA substrates, 
and mediates T-SCE through interaction with MUS81.1 These 
findings, together with the fact that the MUS81 enzymatic 
activity is required for telomere recombination and ALT cell 
viability, support a model that TRF2 suppresses telomere recom-
bination through regulation of the endonuclease activity of 
MUS81 in the ALT pathway (Fig. 2). We observe that there is 
no significant change of telomere circle (t-circle formation) after 
depletion of MUS81 (data not shown), suggesting that t-circles 
may be not involved in MUS81-mediated ALT cell survival. 
However, because a lower level of t-circles may be insufficient to 
detect, we could not rule out the role MUS81 on t-circle forma-
tion. TRF2 mediates t-loop formation and disruption of t-loop 
by TRF2ΔB mutant generates t-circles.10,35,36 MUS81 does not 
interact with TRF2ΔB mutant, implicating that the MUS81 
endonuclease may be involved in the disruption of t-loop, which 
is mediated by TRF2.
The levels of MUS81 protein in G2 phase cells do not change,
1 
suggesting that the recruitment of MUS81 to APBs is subjected 
to regulation in ALT cells. TRF2 and MUS81 interaction suggests 
that TRF2 may regulate MUS81 access to APBs, since TRF2 
affects APBs formation in G0/G1 cells.
15 To test this hypothesis, 
we examine the localization of MUS81 in APBs after depletion 
of TRF2. However, depletion of TRF2 does not change APB 
formation and localization of MUS81 to APBs at G2 phase in 
ALT cells (data not shown), excluding that TRF2 regulates the 
sequences, sister chromatids can find sites of homology anywhere 
to align two telomere strands  asymmetrically. Telomere recombina-
tion results in a gain or loss between two telomeres. The daughter 
cell inheriting chromosomes with elongated telomeres would 
bypass the limits on proliferative potential. Our data indicate that 
MUS81 enhances telomere recombination to maintain the ALT 
cell proliferation without significant alteration of overall telomere 
length, supporting this model.
We do not observe obvious chromosome end-to-end fusion 
in ALT cells after depletion of MUS81 (data not shown). These 
results are consistent with the fact that knockdown of MUS81 do 
not induce the formation of telomere dysfunctional induced-foci 
(data not shown), suggesting that MUS81 does not affect telomere 
end protection in ALT cells. Furthermore, MUS81 depletion do 
not change TRF2 binding on telomeres by the ChIP assay (data 
not shown), supporting this conclusion. Although we observe 
increased telomere loss on some chromosome ends in the MUS81-
depleted ALT cells, it is possible that enough telomere sequences 
are still present in these chromosome ends to ensure chromosome 
end protection.
APBs for Telomere Maintenance
APBs are a hallmark of ALT cells and are usually found in <5% 
of cells within an asynchronously growing ALT cell population. 
Although the function of APBs is not well understood, they have 
been proposed to serve as depots for storage of nuclear factors and 
provide a platform for telomere maintenance in ALT cells.14,33 
The fact that APBs largely increase in G2 phase of the cell cycle 
and that HR is active in this phase has led to the conclusion that 
they function on the maintenance of telomeres by recombination. 
We find that MUS81 specifically localizes to APBs and is enriched 
in G2 phase cells (Fig. 1), supporting the notion that APBs in 
G2 phase are the sites for telomere recombination. MUS81 local-
izes to nucleoli, but is not present in PML bodies in human 
Figure 2. Proposed model for telomere processing in ALT cells. Telomeres move into 
APBs for processing recombination in G2 phase of ALT cells. MUS81 is recruited into 
recombination sites to cleave the recombination structure, which is inhibited by TRF2. 
Elongated telomeres move out from APBs into next phase of the cell cycle.
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recruitment of MUS81 to APBs. Further investigation will be 
needed to clarify which protein is involved in the recruitment of 
MUS81 into APBs.
MUS81 for Telomere Maintenance in ALT Cancer Cells
Our observations demonstrate that MUS81 endonuclease is 
specifically involved in telomere recombination and in the mainte-
nance of ALT cell survival.1 We propose a model where telomeres 
move into APBs for processing recombination based telomere 
maintenance after DNA replication during G2 phase of the cell 
cycle. MUS81 is recruited into recombination sites to cleave the 
recombination structure, for example, D-loop (Fig. 2). TRF2 
negatively regulates the MUS81 enzymatic activity to balance this 
process. Then, telomeres that completed recombination move out 
from APBs into next step of the cell cycle. In this manner, ALT cells 
maintain their telomeres and extend the proliferative lifespan.
The telomere maintenance mechanism is essential for the 
indefinite proliferation of cancer cells. Understanding the specific 
requirements of ALT is key to developing diagnostic tools and 
therapies that target this pathway. Inhibiting telomerase activity 
in non-ALT tumors may activate the ALT pathway, suggesting 
that suppression of ALT activity is important for most tumors. 
MUS81, which is specifically present in APBs and is essential for 
the ALT cell survival, will provide a powerful diagnostic marker 
and a putative therapeutic target for ALT tumors.
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